Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database

Table 2

Self-reported comorbid conditions among ankylosing spondylitis patients commencing biological therapy (n = 198).

Condition	𝑁 (%)
Gastrointestinal disease	62 (31.3)
Hypertension	51 (25.8)
Eye disorder	32 (16.1)
Hypercholesterolaemia	31 (15.6)
Depression	28 (14.1)
Anaemia or other blood disorder	28 (14.1)
Lung disease	21 (10.6)
Neurological disorder	18 (9.0)
Osteoporosis	17 (8.6)
Alcohol and drug	13 (6.6)
Other heart disease	13 (6.5)
Liver disease	7 (3.5)
Thyroid disorder	7 (3.5)
Diabetes Mellitus	7 (3.5)
Cerebrovascular accident	5 (2.5)
Kidney disease	4 (2.0)
Angina	4 (2.0)
Mental illness other than depression	4 (2.0)
Tuberculosis	2 (1.0)